2023 | Association of Physical Activity With Risk of Liver Fibrosis , Sarcopenia, and Cardiovascular Disease in Nonalcoholic Fatty Liver Disease | 유권; 김태헌; 김휘영; 이민종; 이혜아; 전호수 | Article |
2022 | Exercise reduces the risk of chronic kidney disease in individuals with nonalcoholic fatty liver disease: A nationwide cohort study | 이민종; 전호수 | Article |
2023 | Fibrotic Burden in the Liver Differs Across Metabolic Dysfunction-Associated Fatty Liver Disease Subtypes | 이민종; 전호수 | Article |
2023 | MAFLD might be better in identifying subjects with sarcopenia or cardiovascular risk than NAFLD: A nationwide study | 전호수 | Article |
2023 | Metabolic dysfunction associated fatty liver disease identifies subjects with cardiovascular risk better than non-alcoholic fatty liver disease | 이민종; 전호수 | Article |
2024 | PAGE-B incorporating moderate HBV DNA levels predicts risk of HCC among patients entering into HBeAg-positive chronic hepatitis B | 김태헌; 김휘영; 이민종; 이혜아; 전호수; 이한아 | Article |
2021 | Risk of hepatocellular carcinoma in untreated patients with chronic hepatitis b: Independent of hbeag status? | 이민종; 전호수 | Article |
2023 | Risk Stratification for Sarcopenic Obesity in Subjects With Nonalcoholic Fatty Liver Disease | 유권; 김태헌; 김휘영; 이민종; 이혜아; 전호수; 이한아 | Article |
2022 | Transarterial Radioembolization for Unresectable Hepatocellular Carcinoma: Real-Life Efficacy and Safety Analysis of Korean Patients | 전호수 | Article |
2021 | Treatment of direct oral anticoagulants in patients with liver cirrhosis and portal vein thrombosis | 유권; 김휘영; 이민종; 최아름; 전호수 | Review |